GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Current Deferred Revenue

Implantica AG (OSTO:IMP A SDB) Current Deferred Revenue : kr0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Implantica AG's current deferred revenue for the quarter that ended in . 20 was kr0.00 Mil.

Implantica AG Current Deferred Revenue Historical Data

The historical data trend for Implantica AG's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Current Deferred Revenue Chart

Implantica AG Annual Data
Trend
Current Deferred Revenue

Implantica AG Semi-Annual Data
Current Deferred Revenue

Implantica AG Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Implantica AG's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Current Deferred Revenue
Comparable Companies
Traded in Other Exchanges
8IM1:Germany
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Website
https://www.implantica.com
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines